Actionnariat et activité des initiés pour Iovance Biotherapeutics, Inc. (IOVA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $9.87 |
| Capitalisation | $4.4B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-08 | Vogt Frederick G | M-Exempt | 15,626 | |
| 2026-09-08 | Vogt Frederick G | F-InKind | 6,638 | $58K |
| 2026-09-08 | Vogt Frederick G | M-Exempt | 15,626 | |
| 2026-09-08 | BILINSKY IGOR | M-Exempt | 7,813 | |
| 2026-09-08 | BILINSKY IGOR | F-InKind | 3,976 | $35K |
| 2026-09-08 | BILINSKY IGOR | M-Exempt | 7,813 | |
| 2026-09-08 | Puri Raj K. | M-Exempt | 9,766 | |
| 2026-09-08 | Puri Raj K. | F-InKind | 4,478 | $39K |
| 2026-09-08 | Puri Raj K. | M-Exempt | 9,766 | |
| 2026-09-01 | Vogt Frederick G | M-Exempt | 41,669 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $166.5M | $145.4M | $82.2M | $14.0M | $67.3M | $78.2M | $231.7M | $114.9M | $115.7M | $163.1M |
| Placements à Court Terme | 0 | 0 | $386.4M | $293.1M | $562.1M | $426.2M | $240.1M | $165.0M | $208.1M | $133.9M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $151000 | $69.3M | $82.4M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $10.4M | $51.5M | $51.7M |
| Actifs Courants | $169.5M | $149.3M | $475.4M | $316.5M | $636.1M | $508.0M | $479.1M | $307.8M | $457.0M | $442.7M |
| Immobilisations Corporelles | $2.4M | $2.5M | $2.7M | $19.2M | $113.9M | $169.9M | $178.2M | $176.5M | $164.3M | $177.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $229.3M | $282.4M | $279.3M |
| Actifs Totaux | $171.9M | $155.4M | $480.8M | $344.7M | $768.5M | $777.3M | $664.0M | $780.4M | $910.4M | $913.2M |
| Dettes Fournisseurs | $863000 | $1.2M | $2.7M | $15.6M | $13.5M | $27.4M | $26.6M | $33.1M | $27.5M | $22.2M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.0M |
| Passifs Courants | $5.0M | $9.9M | $14.4M | $39.1M | $54.9M | $89.2M | $91.5M | $110.3M | $122.3M | $138.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | $1.0M | $1.0M | $1.0M | $1.0M | 0 |
| Passifs Totaux | $5.0M | $9.9M | $14.6M | $45.7M | $112.0M | $155.7M | $164.3M | $195.7M | $200.0M | $214.6M |
| Réserves | -$157.1M | -$249.2M | -$372.8M | -$570.6M | -$830.2M | -$1.17B | -$1.57B | -$2.01B | -$2.38B | -$2.78B |
| Capitaux Propres | $166.9M | $145.5M | $466.2M | $299.0M | $656.5M | $621.7M | $499.6M | $584.6M | $710.4M | $698.6M |
| Dette Totale | 0 | 0 | 0 | $11.5M | $51.7M | $71.5M | $85.4M | $75.9M | $58.3M | $48.4M |
| Dette Nette | -$166.5M | -$145.4M | -$468.5M | -$295.6M | -$577.8M | -$432.9M | -$386.4M | -$204.0M | -$265.5M | -$248.5M |
| Fonds de Roulement | $164.5M | $139.4M | $461.0M | $277.4M | $581.2M | $418.8M | $387.6M | $197.5M | $334.7M | $304.3M |
Santé financière
| Dette / Capitaux propres | 0.06 |
| Ratio de liquidité | 4.35 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -2.30 |
Rentabilité
| Rentabilité des capitaux propres | -40.51% |
| Rentabilité du capital investi | -36.60% |
| Rentabilité des actifs | -31.62% |
| Marge brute | 116.30% |
| Marge opérationnelle | -92.72% |
| Marge nette | -89.09% |
Entreprises liées: ATXS · AVBP · CTMX · DNA · ERAS · MBX · MGTX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de IOVA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions